FDA Alert: Rituxan (rituximab) - PML
Links shared publicly online about this topic.
- 1,653total visits
FDA Alert: Rituxan (rituximab) - PML
View full resource at drugs.com
Tags: Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, FDA, Rituxan, MabThera
Most Recently Shared on October 24, 2009 at 2:10 pm By:
RT @drugscom FDA Alert: Rituxan (rituximab) - PML http://bit.ly/2QIfwP
Medical News: FDA Okays Drug for Rare Blood Vessel Disorders - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA approved the non-Hodgkin's lymphoma treatment rituximab (Rituxan) for use with steroids in patients with two rare blood-vessel inflammation disorders.” View full resource at medpagetoday.com
Most Recently Shared on April 21, 2011 at 4:17 pm By:
FDA Okays Drug for Rare Blood Vessel Disorders http://bit.ly/fJA9MR
Rituxan Gains Indication for Severe Vasculitis - MPR
empr.com — “The FDA has approved Rituxan (rituximab; Genentech) in combination with corticosteroids for the treatment of adults with Wegener--™s granulomatosis and microscopic polyangiitis, two forms of severe ANCA-associated vasculitis.” View full resource at empr.com
Most Recently Shared on April 20, 2011 at 2:16 pm By:
MPR News: Rituxan Gains Indication for Severe Vasculitis: The FDA has approved Rituxan (rituximab; Genentech) in... http://bit.ly/hHmGuo
Rituxan Gains Indication for Severe Vasculitis - ONA
oncologynurseadvisor.com — “The FDA has approved Rituxan (rituximab; Genentech) in combination with corticosteroids for the treatment of adults with Wegener--™s granulomatosis and microscopic polyangiitis, two forms of severe ANCA-associated vasculitis.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 20, 2011 at 2:07 pm By:
Rituxan Gains Indication for Severe Vasculitis http://goo.gl/fb/isLrx
FDA Approves Rituxan To Treat Two Rare Disorders
medicalnewstoday.com — “The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener's granulomatosis (WG) and microscopic polya” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2011 at 8:05 am By:
FDA Approves Rituxan To Treat Two Rare Disorders http://mnt.to/3TRb #regulatory
Rituxan gains indication for first-line maintenance use in follicular lymphoma - ONA
oncologynurseadvisor.com — “Genentech announced that the FDA has approved Rituxan (rituximab) as maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 31, 2011 at 4:40 pm By:
Rituxan gains indication for first-line maintenance use in follicular lymphoma http://goo.gl/fb/w6938
Rituxan gains indication for first-line maintenance use in follicular lymphoma - MPR
empr.com — “Genentech announced that the FDA has approved Rituxan (rituximab) as maintenance treatment for patients with advanced follicular lymphoma who responded to initial treatment with Rituxan plus chemotherapy.” View full resource at empr.com
Most Recently Shared on January 31, 2011 at 4:18 pm By:
MPR News: Rituxan gains indication for first-line maintenance use in follicular lymphoma: Genentech announced th... http://bit.ly/hWnvVc
Rituximab Approved as Lymphoma Maintenance - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The FDA has approved use of rituximab (Rituxan) as maintenance therapy for advanced follicular lymphoma in patients with an initial response to induction therapy with the drug plus chemotherapy, its manufacturers said.” View full resource at qualitypointtech.net
Most Recently Shared on January 29, 2011 at 1:47 pm By:
Rituximab Approved as Lymphoma Maintenance: (MedPage Today) -- The FDA has approved use of rituximab (Rituxan) as ... http://bit.ly/e9Ajrq
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
drugs.com — “Rituxan (rituximab) is used to treat Chronic Lymphocytic Leukemia. Includes Rituxan side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 22, 2010 at 11:41 pm By:
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia - http://bit.ly/960vQR
US FDA Approves Rituxan/MabThera For The Most Common Type Of Adult Leukemia
medicalnewstoday.com — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) approved Rituxan/MabThera (rituximab) plus fludarabine and cyclophosphamide (FC) chemotherapy for people” View full resource at medicalnewstoday.com
Most Recently Shared on February 20, 2010 at 4:06 pm By:
US FDA Approves Rituxan/MabThera For The Most Common Type Of Adult Leukemia http://mnt.to/3xV7 #lymphoma #leukemia
Rituxan approved for chronic lymphocytic leukemia - MPR
empr.com — “The FDA has approved Rituxan (rituximab, from Genentech) in combination with fludarabine and cyclophosphamide (FC) for patients with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).” View full resource at empr.com
Most Recently Shared on February 19, 2010 at 3:50 pm By:
MPR News: Rituxan approved for chronic lymphocytic leukemia: The FDA has approved Rituxan (rituximab, from Genente... http://bit.ly/deIPpG
Supplemental BLAs submitted for Rituxan for chronic lymphocytic leukemia - MPR
empr.com — “Genentech and Biogen Idec announced that they submitted two supplemental Biologics License Applications (sBLAs), along with a priority review request, to the FDA for Rituxan (rituximab) plus standard (fludarabine and cyclophosphamide) chemotherapy for patients with previously untreated or treated chronic lymphocytic leukemia (CLL).” View full resource at empr.com
Most Recently Shared on May 20, 2009 at 9:30 pm By:
MPR News: Supplemental BLAs submitted for Rituxan for chronic lymphocytic leukemia: Genentech and Bioge.. http://tinyurl.com/posl4z
Advertisement

